Back    Zoom +    Zoom -
<Research>Citi Initiates Pair Trade of Overweight CHINA LIFE/ Underweight NCI
Recommend
19
Positive
55
Negative
22
Citi Research issued a research report initiating the pair trade of overweight CHINA LIFE (02628.HK) and underweight NCI (01336.HK). The broker rated NCI at Neutral, has a PB ratio of 1.6x after its recent rally, and rated CHINA LIFE at Buy, with a PB ratio of only 1x.

Citi Research believed that the gap is partly driven by NCI's profit alert expecting a 45-65% growth in earnings for 9M25, while the market may have overlooked CHINA LIFE's strong sales momentum in 3Q25 and reasonable investment returns.

Related NewsCiti: CN Insurers' Quarterly Results Expected to Be Driven by Maturing Deposit Allocation/ Improvement in CoR
The broker's target prices for NCI/ CHINA LIFE are $50.7/ $27.7, respectively.
AASTOCKS Financial News
Website: www.aastocks.com